Welcome Note
Dear Colleagues,
Jörg Fuchs and Rupert Handgretinger
During the past, advances in treatment and outcome of children suffering from Neuroblastoma have been made by European and American multicenter trials. Besides conservative treatment approaches, novel therapies are more and more important. In 2012, the 20th anniversary of antibody therapy in Neuroblastoma can be celebrated in Tübingen.
Additionally, the world’s first MIBG treatment in Neuroblastoma was carried out in Tübingen. Therefore, we would like to invite you to Tübingen to discuss treatment of Neuroblastoma. The topic from bench to bedside will draw a bow from basic research to clinical treatment approaches and problems.
International experts from the fields of pediatric oncology, pediatric surgery, radiooncology, nuclear medicine, immunology, radiology, and genetics will be together discussing actual topics of Neuroblastoma.
Abstracts may be submitted for all scientific sessions. Authors are also encouraged to submit clinical case presentations. Tübingen is known to be a comprehensive center for medical care, research and teaching.
We are looking forward to having you here in Tübingen.
| Jörg Fuchs Professor of Pediatric Surgery |
Rupert Handgretinger Professor of Pediatric Oncology |
Please find here the flyer as pdf-file 
Layout based on YAML